Anagenesis Biotechnologies is Biotechnology in France that focus on brown fat business. Founded in 2011. They cover business area such as developer, novel treatment, genetic and age-relate muscle degenerative disease, pluripotent stem cell, iPSC, paraxial mesoderm multipotent cell, various tissue, skeletal muscle, rib, vertebrae, dermis, endothelium, brown fat, enable physician, muscle formation.
2011
( 13 years old in 2024 )
Brown Fat
-
Parc d'innovation - BioParc 3
850 Boulevard Sébastien Brant
67400 Illkirch Graffenstaden
France
Private
developernovel treatmentgenetic and age-relate muscle degenerative diseasepluripotent stem celliPSCparaxial mesoderm multipotent cellvarious tissueskeletal muscleribvertebraedermisendotheliumbrown fatenable physicianmuscle formation
* We use standard office opening hours in near Anagenesis Biotechnologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Anagenesis Biotechnologies is Biotechnology business from France that founded in 2011 (13 years old in 2024), Anagenesis Biotechnologies business is focusing on Brown Fat.
Anagenesis Biotechnologies headquarter office and corporate office address is located in Parc d'innovation - BioParc 3 850 Boulevard Sébastien Brant 67400 Illkirch Graffenstaden France.
Anagenesis Biotechnologies was founded in France.
In 2024, Anagenesis Biotechnologies is currently focus on brown fat sector.
Above is snippet of Google Trends for "brown fat" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Anagenesis Biotechnologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
